Results · Apr-Jun 2026
Kwality Pharmaceuticals Q1 FY27 results
BlockbusterBlockbuster: sales up 20% or more & profit up 30% or more on the same quarter last year, with a wider operating margin.
Sales grew 46% to ₹162 crore from ₹111 crore in Apr-Jun 2025.
Operating profit grew 70% to ₹41 crore, an operating margin of 25.3% (up 3.6 points from a year ago).
Net profit grew 115% to ₹25.6 crore from ₹11.9 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +3%, net profit +1%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 162.4 | 111.5 | +46% |
| Operating profit (EBITDA) | 41.0 | 24.2 | +70% |
| Operating margin | 25.3% | 21.7% | +3.6 pts |
| Net profit | 25.6 | 11.9 | +115% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.